Therapeutic targeting of gastrointestinal cancer stem cells

Regen Med. 2019 May;14(4):331-343. doi: 10.2217/rme-2018-0146. Epub 2019 Apr 26.

Abstract

Gastrointestinal cancers remain a tremendous burden on society. Despite advances in therapy options, including chemotherapy and radiation, cancer mortality from recurrences and metastases occur frequently. Cancer stem cells (CSCs) drive disease recurrence and metastasis, as these cells are uniquely equipped to self-renew and evade therapy. Therefore, cancer eradication requires treatment strategies that target CSCs in addition to differentiated cancer cells. This review highlights current literature on therapies targeting CSCs in gastrointestinal cancer.

Keywords: cancer stem cells; chemoresistance; gastrointestinal cancer; immunotherapy; radioresistance; targeted therapies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • DNA Damage
  • Gastrointestinal Neoplasms / immunology
  • Gastrointestinal Neoplasms / therapy*
  • Humans
  • Immunotherapy
  • Molecular Targeted Therapy*
  • Neoplastic Stem Cells / pathology*
  • Oxidation-Reduction